SLC1A1: Solute Carrier Family 1 Member 1
Glutamate Transporter EAAT3 in Neurotransmission and Metabolism
Gene Information Card
| Symbol | SLC1A1 |
|---|---|
| Full Name | Solute Carrier Family 1 Member 1 |
| Gene Type | protein-coding |
| Chromosomal Location | 9p24.2 |
| NCBI Gene ID | 6505 ncbi.nlm.nih.gov/gene/6505 |
| Ensembl ID | ENSG00000106688 |
| UniProt ID | P43004 |
| OMIM ID | 133550 |
| HGNC ID | 10941 |
| Aliases | EAAT3, EAAC1, EAAT3 |
Description
SLC1A1 (Solute Carrier Family 1 Member 1) encodes the excitatory amino acid transporter 3 (EAAT3), a sodium- and potassium-coupled high-affinity glutamate transporter. EAAT3 is primarily expressed in neurons, kidney, and intestine, where it mediates the uptake of L-glutamate and L-aspartate. It plays a critical role in terminating glutamatergic neurotransmission, maintaining glutamate homeostasis, and providing glutamate for glutathione synthesis. Mutations in SLC1A1 cause dicarboxylic aminoaciduria (OMIM 222730) and have been implicated in obsessive-compulsive disorder, schizophrenia, and epilepsy.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Dicarboxylic Aminoaciduria | Loss-of-function mutations impair renal and intestinal reabsorption of glutamate and aspartate, leading to increased urinary excretion. | OMIM 222730, ClinVar |
| Obsessive-Compulsive Disorder (OCD) | Altered glutamate transport in cortico-striatal circuits; SLC1A1 variants associated with OCD susceptibility. | PMID 16936799, 17997358 |
| Schizophrenia | Reduced EAAT3 expression in prefrontal cortex may contribute to glutamatergic dysfunction. | PMID 18385393 |
| Epilepsy | Impaired glutamate clearance leads to excitotoxicity and seizure susceptibility. | PMID 21402109 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Brain | 12.5 | High |
| Kidney | 8.2 | Medium |
| Small Intestine | 6.1 | Medium |
| Liver | 1.3 | Low |
| Heart | 0.8 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| SH-SY5Y (neuroblastoma) | 15.3 | High expression |
| HEK293 (embryonic kidney) | 9.7 | Moderate expression |
| Caco-2 (colorectal) | 5.4 | Low expression |
| HepG2 (hepatocellular) | 1.1 | Very low |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1285C>T (p.Arg429*) | Nonsense | <0.01% | Loss of function; truncation of EAAT3 |
| c.1199G>A (p.Arg400His) | Missense | <0.01% | Reduced glutamate transport activity |
| c.154G>A (p.Gly52Arg) | Missense | <0.01% | Impaired trafficking to plasma membrane |
| c.1A>G (p.Met1?) | Start loss | <0.01% | No protein production |
Mutation functional classification
Loss of Function (LOF)
Nonsense and missense mutations (e.g., p.Arg429*, p.Arg400His) reduce or abolish glutamate transport, causing dicarboxylic aminoaciduria.
Gain of Function (GOF)
No confirmed gain-of-function mutations reported in SLC1A1.
Dominant Negative (DN)
Not established; SLC1A1 functions as a monomer, dominant-negative effects are unlikely.
View complete mutation data:
Gene Ontology (GO)
| • L-glutamate transmembrane transporter activity (GO:0005313) | • L-aspartate transmembrane transporter activity (GO:0015183) |
| • plasma membrane (GO:0005886) | • integral component of membrane (GO:0016021) |
| • sodium ion transport (GO:0006814) | • neurotransmitter transport (GO:0006836) |
| • response to drug (GO:0042493) |
Pathways
• Glutamatergic synapse (KEGG hsa04724)
• Neuroactive ligand-receptor interaction (KEGG hsa04080)
• Transport of glucose and other sugars
• bile salts and organic acids
• metal ions and amine compounds (Reactome R-HSA-425366)
Protein Summary
EAAT3 (Excitatory Amino Acid Transporter 3) is a 523-amino acid membrane protein with 8-10 transmembrane domains. It couples the transport of one glutamate molecule with the co-transport of three Na+ and one H+ and the counter-transport of one K+. EAAT3 is the major neuronal glutamate transporter in the brain and also mediates the uptake of cysteine for glutathione synthesis, linking it to antioxidant defense. The protein is localized to the plasma membrane and intracellular vesicles, with regulated trafficking in response to neuronal activity.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SLC1A1 Knockout HEK293 Cell Line | EDJ-KQ5760 | Human | 6505 | Details Get a Quote |
| SLC1A1 Knockout A-549 Cell Line | EDJ-KQ29174 | Human | 6505 | Details Get a Quote |
| SLC1A1 Knockout HCT 116 Cell Line | EDJ-KQ29175 | Human | 6505 | Details Get a Quote |
| SLC1A1 Knockout HeLa Cell Line | EDJ-KQ29176 | Human | 6505 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records